BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31235847)

  • 1. Early pregnancy serum levels of perfluoroalkyl substances and risk of preeclampsia in Swedish women.
    Wikström S; Lindh CH; Shu H; Bornehag CG
    Sci Rep; 2019 Jun; 9(1):9179. PubMed ID: 31235847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study.
    Starling AP; Engel SM; Richardson DB; Baird DD; Haug LS; Stuebe AM; Klungsøyr K; Harmon Q; Becher G; Thomsen C; Sabaredzovic A; Eggesbø M; Hoppin JA; Travlos GS; Wilson RE; Trogstad LI; Magnus P; Longnecker MP
    Am J Epidemiol; 2014 Apr; 179(7):824-33. PubMed ID: 24557813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with hypertensive disorders of pregnancy in the Atlanta African American Maternal-Child cohort.
    Thompson M; Eatman JA; Dunlop AL; Barr DB; Kannan K; Corwin EJ; Ryan PB; Panuwet P; Yakimavets V; Taibl KR; Tan Y; Liang D; Eick SM
    Chemosphere; 2024 Jun; 357():142052. PubMed ID: 38631500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure to perfluoroalkyl substances in early pregnancy and risk of sporadic first trimester miscarriage.
    Wikström S; Hussein G; Lingroth Karlsson A; Lindh CH; Bornehag CG
    Sci Rep; 2021 Feb; 11(1):3568. PubMed ID: 33574373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and the risk of hypertensive disorders of pregnancy.
    Huang R; Chen Q; Zhang L; Luo K; Chen L; Zhao S; Feng L; Zhang J
    Environ Health; 2019 Jan; 18(1):5. PubMed ID: 30626391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Associated with Maternal Serum Levels of Perfluoroalkyl Substances and Organochlorines: A Descriptive Study of Parous Women in Norway and Sweden.
    Lauritzen HB; Larose TL; Øien T; Odland JØ; van de Bor M; Jacobsen GW; Sandanger TM
    PLoS One; 2016; 11(11):e0166127. PubMed ID: 27824939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-Pregnancy Plasma Concentrations of Perfluoroalkyl Substances and Birth Outcomes in Project Viva: Confounded by Pregnancy Hemodynamics?
    Sagiv SK; Rifas-Shiman SL; Fleisch AF; Webster TF; Calafat AM; Ye X; Gillman MW; Oken E
    Am J Epidemiol; 2018 Apr; 187(4):793-802. PubMed ID: 29155920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of perfluoroalkyl substances with gestational hypertension and preeclampsia in the MIREC study.
    Borghese MM; Walker M; Helewa ME; Fraser WD; Arbuckle TE
    Environ Int; 2020 Aug; 141():105789. PubMed ID: 32408216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal trends and predictors of perfluoroalkyl substances serum levels in Swedish pregnant women in the SELMA study.
    Shu H; Lindh CH; Wikström S; Bornehag CG
    PLoS One; 2018; 13(12):e0209255. PubMed ID: 30596681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants and Temporal Trends of Perfluoroalkyl Substances in Pregnant Women: The Hokkaido Study on Environment and Children's Health.
    Tsai MS; Miyashita C; Araki A; Itoh S; Bamai YA; Goudarzi H; Okada E; Kashino I; Matsuura H; Kishi R
    Int J Environ Res Public Health; 2018 May; 15(5):. PubMed ID: 29758015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum levels of perfluoroalkyl substances in early pregnancy and offspring birth weight.
    Wikström S; Lin PI; Lindh CH; Shu H; Bornehag CG
    Pediatr Res; 2020 May; 87(6):1093-1099. PubMed ID: 31835271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal Plasma Perfluoroalkyl Substances and Miscarriage: A Nested Case-Control Study in the Danish National Birth Cohort.
    Liew Z; Luo J; Nohr EA; Bech BH; Bossi R; Arah OA; Olsen J
    Environ Health Perspect; 2020 Apr; 128(4):47007. PubMed ID: 32319790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
    Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum levels of perfluoroalkyl substances with gestational diabetes mellitus and postpartum blood glucose.
    Wang Y; Zhang L; Teng Y; Zhang J; Yang L; Li J; Lai J; Zhao Y; Wu Y
    J Environ Sci (China); 2018 Jul; 69():5-11. PubMed ID: 29941268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfluoroalkyl Acids in Maternal Serum and Indices of Fetal Growth: The Aarhus Birth Cohort.
    Bach CC; Bech BH; Nohr EA; Olsen J; Matthiesen NB; Bonefeld-Jørgensen EC; Bossi R; Henriksen TB
    Environ Health Perspect; 2016 Jun; 124(6):848-54. PubMed ID: 26495857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy-induced changes in serum concentrations of perfluoroalkyl substances and the influence of kidney function.
    Nielsen C; Andersson Hall U; Lindh C; Ekström U; Xu Y; Li Y; Holmäng A; Jakobsson K
    Environ Health; 2020 Jul; 19(1):80. PubMed ID: 32641055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to Perfluoroalkyl Substances and Metabolic Outcomes in Pregnant Women: Evidence from the Spanish INMA Birth Cohorts.
    Matilla-Santander N; Valvi D; Lopez-Espinosa MJ; Manzano-Salgado CB; Ballester F; Ibarluzea J; Santa-Marina L; Schettgen T; Guxens M; Sunyer J; Vrijheid M
    Environ Health Perspect; 2017 Nov; 125(11):117004. PubMed ID: 29135438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal Exposure to Perfluoroalkyl Substances and Cardiometabolic Risk in Children from the Spanish INMA Birth Cohort Study.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Romaguera D; Fernández-Barrés S; Santa-Marina L; Basterretxea M; Schettgen T; Valvi D; Vioque J; Sunyer J; Vrijheid M
    Environ Health Perspect; 2017 Sep; 125(9):097018. PubMed ID: 28934720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menstrual cycle characteristics as determinants of plasma concentrations of perfluoroalkyl substances (PFASs) in the Norwegian Mother and Child Cohort (MoBa study).
    Singer AB; Whitworth KW; Haug LS; Sabaredzovic A; Impinen A; Papadopoulou E; Longnecker MP
    Environ Res; 2018 Oct; 166():78-85. PubMed ID: 29879567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and childhood atopic dermatitis: a prospective birth cohort study.
    Chen Q; Huang R; Hua L; Guo Y; Huang L; Zhao Y; Wang X; Zhang J
    Environ Health; 2018 Jan; 17(1):8. PubMed ID: 29343261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.